Attached files

file filename
EX-17.1 - EXHIBIT 17.1 - Protea Biosciences Group, Inc.v387168_ex17-1.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): August 18, 2014

 

PROTEA BIOSCIENCES GROUP, INC.

(Exact name of registrant as specified in its charter)

 

Delaware 000-51474 20-2903252
(State or other jurisdiction of 
incorporation or organization)
(Commission File Number) (IRS Employer Identification No.)

 

955 Hartman Run Road

Morgantown, West Virginia 26505


(Address of principal executive offices)(Zip Code)

 

(304) 292-2226


(Registrant’s telephone number, including area code)

 

No change 


(Former name or former address, if changed since last report)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) 

 

 

 
 

  

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On August 18, 2014, Thijs Spoor notified Protea Biosciences Group, Inc. (the “Company”) that he would resign from his position as a member of the board of directors of the Company, effective immediately. Mr. Spoor’s resignation was not the result of a disagreement with the Company on any matter relating to the Company's operations, policies or practices. Mr. Spoor’s resignation letter is attached as Exhibit 17.1.

 

Item 9.01Exhibits.

 

(d) Exhibits

 

17.1Letter of Resignation of Thijs Spoor.

 

 

SIGNATURES 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

Dated: August 18, 2014 PROTEA BIOSCIENCES GROUP, INC.
   
   
  By:  /s/ Stephen Turner
    Stephen Turner
Chief Executive Officer